Age-related differences in NMDA receptor subunits of prenatally methamphetamine-exposed male rats. 2014

Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
Prague Psychiatric Center, Ustavni 91, 181 03, Prague 8, Czech Republic, vrajova@pcp.lf3.cuni.cz.

There is accumulating evidence that methamphetamine (MA) is a widely abused drug popular among pregnant women. MA exposure is associated with changes in the function of neurotransmitter systems, namely the dopaminergic, serotonergic and glutamatergic systems. Since N-methyl-D-aspartate receptors (NMDA) are affected by MA-induced glutamate release, we assessed the expression of NMDAR subunits (NR1, NR2A, and NR2B) and postsynaptic density protein 95 (PSD-95), which is connected with NMDAR. We measured the expression of these proteins in adolescent (30 days old) and adult (60 days old) rat males exposed to MA during the entire prenatal period and compared them with the same parameters in age matched saline-exposed rats. There was a significant increase in the NR1 and NR2B subunits in the hippocampus of adult males, but not in adolescent males. We identified a significant change in adult MA-induced rats when compared to adult controls for NR2A and NR2B, while in adolescent MA rats this change was close to the boundary of significance. In summary, our study suggests that prenatal MA exposure is connected with changes in NMDAR subunit expression in adult rats but not in adolescent rats.

UI MeSH Term Description Entries
D008297 Male Males
D008694 Methamphetamine A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed. Deoxyephedrine,Desoxyephedrine,Desoxyn,Madrine,Metamfetamine,Methamphetamine Hydrochloride,Methylamphetamine,N-Methylamphetamine,Hydrochloride, Methamphetamine,N Methylamphetamine
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011297 Prenatal Exposure Delayed Effects The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. Delayed Effects, Prenatal Exposure,Late Effects, Prenatal Exposure
D005260 Female Females
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
November 2005, Naunyn-Schmiedeberg's archives of pharmacology,
Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
June 2016, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,
Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
January 2009, Physiological research,
Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
January 2014, Prague medical report,
Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
June 2005, Epilepsy research,
Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
October 2005, Brain research,
Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
August 2014, Behavioural brain research,
Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
January 1991, Neurotoxicology and teratology,
Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
February 2002, Brain research. Molecular brain research,
Monika Vrajová, and Barbora Schutová, and Jan Klaschka, and Hana Stěpánková, and Daniela Rípová, and Romana Šlamberová
January 2012, Physiological research,
Copied contents to your clipboard!